Latest news
Cabotegravir, Rilpivirine Outperforms Daily HIV Therapy in Adolescents - Drug TopicsDrug Topics · Tue, 04 Aug 2026 16:07:51 GMTCabenuva Beats Daily Oral Therapy in Adolescents With HIV in LATA Trial - Contagion LiveContagion Live · Tue, 04 Aug 2026 12:27:16 GMTCabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - GSKGSK · Wed, 29 Jul 2026 07:00:00 GMT[Press release] Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - European AIDS Treatment GroupEuropean AIDS Treatment Group · Wed, 29 Jul 2026 07:00:00 GMTLong-acting Cabenuva beats daily oral HIV therapy in adolescents | AIDS 2026 - Managed Healthcare ExecutiveManaged Healthcare Executive · Wed, 29 Jul 2026 07:00:00 GMTHIV Preventative Service Coverage Tables | High Quality Care - Centers for Disease Control and Prevention | CDC (.gov)Centers for Disease Control and Prevention | CDC (.gov) · Mon, 27 Jul 2026 07:00:00 GMT